Show simple item record

dc.contributor.authorNes, Lise Solberg
dc.contributor.authorBørøsund, Elin
dc.contributor.authorVarsi, Cecilie
dc.contributor.authorEide, Hilde
dc.contributor.authorWaxenberg, Lori B.
dc.contributor.authorWeiss, Karen E.
dc.contributor.authorMorrison, Eleshia J.
dc.contributor.authorStøle, Hanne Stavenes
dc.contributor.authorKristjansdottir, Olöf Birna
dc.contributor.authorBostrøm, Katrine
dc.contributor.authorStrand, Elin Bolle
dc.contributor.authorSmåstuen, Milada Cvancarova
dc.contributor.authorStubhaug, Audun
dc.contributor.authorSchreurs, Karlein M. G.
dc.date.accessioned2024-08-02T13:30:37Z
dc.date.available2024-08-02T13:30:37Z
dc.date.created2024-07-04T13:04:33Z
dc.date.issued2024
dc.identifier.citationSolberg Nes, L., Børøsund, E., Varsi, C., Eide, H., Waxenberg, L. B., Weiss, K. E., Morrison, E. J., Støle, H. S., Kristjansdottir, Ó. B., Bostrøm, K., Strand, E. B., Hagen, M. C. S., Stubhaug, A., & Schreurs, K. M. G. (2024). Living well with chronic pain: a 12-month randomized controlled trial revealing impact from the digital pain self-management program EPIO. PAIN Reports, 9(4), Artikkel e1174.en_US
dc.identifier.issn2471-2531
dc.identifier.urihttps://hdl.handle.net/11250/3144255
dc.description.abstractIntroduction: Chronic pain affects a wide range of physical and psychological aspects of life for those impacted. Psychosocial treatment approaches may be of support, but outreach is still limited. Objectives: To evaluate the efficacy of EPIO, an evidence-informed, user-centered digital self-management intervention for people with chronic pain, in a 12-month randomized controlled trial. Methods: People living with chronic pain (N = 266) were randomized to the EPIO intervention (n = 132) or a usual-care control group (n = 134). The intervention was delivered in a simple blended care model, and outcome measures collected at baseline, 6 months, and 12 months. Generalized linear models for repeated measures were fitted to compare groups over time. Results: Participants were primarily female (81%), median age 49 years (range 22–78), with heterogeneous pain conditions, and had lived with pain >5 years (77.6%). A mixed linear model with all timepoints included revealed no statistically significant group differences for the primary outcome of pain interference. Significant psychological benefits in favor of the intervention group were however detected for depression (P = 0.022), self-regulatory fatigue (P = 0.024), vitality (P = 0.016), and mental health (P = 0.047). Baseline to 12-month changes showed additional favorable effects for anxiety (between-group mean differences [MDs] = 0.79, P = 0.047), depression (MD = 1.08, P = 0.004), self-regulatory fatigue (MD = 2.42, P = 0.021), pain catastrophizing (MD = 2.62, P = 0.009), and health-related quality of life. Conclusions: The EPIO program aims to improve outreach of evidence-based pain self-management interventions. Findings demonstrate how using EPIO can lead to sustainable psychological change, enhancing mental health and health-related quality of life for people suffering from pain, providing a chance to live well with the pain.en_US
dc.language.isoengen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleLiving well with chronic pain: a 12-month randomized controlled trial revealing impact from the digital pain self-management program EPIOen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2024 The Author(s).en_US
dc.source.volume9en_US
dc.source.journalPain Reportsen_US
dc.source.issue4en_US
dc.identifier.doihttps://doi.org/10.1097/PR9.0000000000001174
dc.identifier.cristin2281063
dc.source.articlenumbere1174en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal